ABSCIENCES (EPA:AB) AB Science announced that an abstract on the long-term survival of masitinib in ALS has been selected for a platform presentation at the Annual Meeting of the Spanish Society of Neurology
Transparency directive : regulatory news
20/09/2021 19:15